NINTH SUPPLEMENTAL INDENTURENinth Supplemental Indenture • December 19th, 2022 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
This Ninth Supplemental Indenture (this “Supplemental Indenture”), is entered into as of December 15, 2022, among Quotient Limited, a public limited liability no par value company formed under the laws of Jersey, Channel Islands (the “Issuer”), the Guarantors party hereto, and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
